To be clear: This is a diabetes drug first. It’s not a new drug class. One could consider me, personally, a “long term” study as I’ve been on a GLP-1 RA for over a decade. I still use one (albeit a newer one, Mounjaro) and it’s a required part of my T2D management.

Losing access to it because the masses think it’s a weight loss drug and consume all the supply means my management suffers.

Weight loss is off-label.

#Diabetes #T2D #GLP1RA #StopUsingMyDrugsOffLabel